Patients' understanding of risk.
作者信息
Thornton Hazel
出版信息
BMJ. 2003 Sep 27;327(7417):693-4. doi: 10.1136/bmj.327.7417.693.
Abstract
摘要
相似文献
1
Patients' understanding of risk.患者对风险的理解。
BMJ. 2003 Sep 27;327(7417):693-4. doi: 10.1136/bmj.327.7417.693.
2
Ways to optimize understanding health related information: the patients' perspective.优化理解健康相关信息的方法：患者视角。
Geriatr Nurs. 2011 Jan-Feb;32(1):29-38. doi: 10.1016/j.gerinurse.2010.09.001. Epub 2010 Nov 4.
3
Primary care patients' recognition of their own risk for cardiovascular disease: implications for risk communication in practice.基层医疗患者对自身心血管疾病风险的认知：对实际风险沟通的启示
Curr Opin Cardiol. 2008 Sep;23(5):471-6. doi: 10.1097/HCO.0b013e32830b35f6.
4
Is seeing believing?眼见为实吗？
J Clin Oncol. 2010 Feb 10;28(5):711-3. doi: 10.1200/JCO.2009.25.0720. Epub 2010 Jan 11.
5
[Assessment of factors associated with patients' comprehension of treatment at the start of antiretroviral therapy].[抗逆转录病毒治疗开始时与患者治疗理解相关因素的评估]
Enferm Infecc Microbiol Clin. 2009 Jan;27(1):7-13. doi: 10.1016/j.eimc.2008.05.003. Epub 2009 Jan 9.
6
Exploring patient experiences with prescription medicines to identify unmet patient needs: implications for research and practice.探索患者对处方药物的体验，以确定未满足的患者需求：对研究和实践的启示。
Res Social Adm Pharm. 2012 Jul-Aug;8(4):321-32. doi: 10.1016/j.sapharm.2011.08.003. Epub 2012 Jan 4.
7
Understanding patients' health beliefs.
Prof Nurse. 1999 Feb;14(5):320-2.
8
The effectiveness of personalized coronary heart disease and stroke risk communication.个性化冠心病和中风风险沟通的效果。
Am Heart J. 2011 Apr;161(4):673-80. doi: 10.1016/j.ahj.2010.12.021.
9
Progress in cancer care: the hope, the hype, and the gap between reality and perception.癌症护理的进展：希望、炒作以及现实与认知之间的差距。
J Clin Oncol. 2008 Nov 1;26(31):5020-1. doi: 10.1200/JCO.2008.17.6198. Epub 2008 Sep 15.
10
Understanding the attitudes of the elderly towards enrolment into cancer clinical trials.了解老年人对参与癌症临床试验的态度。
BMC Cancer. 2006 Feb 8;6:34. doi: 10.1186/1471-2407-6-34.
引用本文的文献
1
Focus groups highlight that many patients object to clinicians' focusing on costs.焦点小组强调，许多患者反对临床医生关注成本。
Health Aff (Millwood). 2013 Feb;32(2):338-46. doi: 10.1377/hlthaff.2012.0686.
2
Patient adherence to aromatase inhibitor treatment in the adjuvant setting.辅助治疗中芳香化酶抑制剂治疗的患者依从性。
Curr Oncol. 2011 May;18 Suppl 1(Suppl 1):S3-9. doi: 10.3747/co.v18i0.899.
3
Absolute risk representation in cardiovascular disease prevention: comprehension and preferences of health care consumers and general practitioners involved in a focus group study.心血管疾病预防中的绝对风险表示：参与焦点小组研究的医疗保健消费者和全科医生的理解和偏好。
BMC Public Health. 2010 Mar 4;10:108. doi: 10.1186/1471-2458-10-108.
4
Insecurity and risk in the consultation.咨询中的不安全感与风险。
Br J Gen Pract. 2009 Jul;59(564):548-9. doi: 10.3399/bjgp09X453666.
5
"Please, I want to go home": ethical issues raised when considering choice of place of care in palliative care.“求你了，我想回家”：姑息治疗中考虑护理地点选择时引发的伦理问题
Postgrad Med J. 2007 Oct;83(984):643-8. doi: 10.1136/pgmj.2007.058487.
6
Clinical risk management of herb-drug interactions.草药-药物相互作用的临床风险管理
Br J Clin Pharmacol. 2007 Mar;63(3):258-67. doi: 10.1111/j.1365-2125.2006.02797.x. Epub 2006 Nov 20.
7
An assessment of risk understanding in Hispanic genetic counseling patients.
J Genet Couns. 2005 Aug;14(4):319-28. doi: 10.1007/s10897-005-0759-5.
8
Challenging times for food allergy tests.食物过敏测试面临挑战的时期。
Arch Dis Child. 2005 Jun;90(6):564-6. doi: 10.1136/adc.2003.036814.
9
Patient motivations surrounding participation in phase I and phase II clinical trials of cancer chemotherapy.围绕参与癌症化疗I期和II期临床试验的患者动机。
Br J Cancer. 2005 Mar 28;92(6):1001-5. doi: 10.1038/sj.bjc.6602423.
10
Screening for breast cancer.乳腺癌筛查
JAMA. 2005 Mar 9;293(10):1245-56. doi: 10.1001/jama.293.10.1245.
本文引用的文献
1
Trusting technology: women aged 40-49 years participating in screening for breast cancer--an exploratory study.信任技术：40至49岁参与乳腺癌筛查的女性——一项探索性研究。
Aust N Z J Public Health. 2003;27(3):282-6. doi: 10.1111/j.1467-842x.2003.tb00395.x.
2
Evolving the multiple roles of 'patients' in health-care research: reflections after involvement in a trial of shared decision-making.探讨医疗保健研究中“患者”角色的演变：参与共同决策试验后的思考
Health Expect. 2003 Sep;6(3):189-97. doi: 10.1046/j.1369-6513.2003.00231.x.
3
Breast cancer and hormone-replacement therapy in the Million Women Study.百万女性研究中的乳腺癌与激素替代疗法
Lancet. 2003 Aug 9;362(9382):419-27. doi: 10.1016/s0140-6736(03)14065-2.
4
Informed consent for breast screening: what should we tell women?
J Med Screen. 2003;10(1):22-6. doi: 10.1258/096914103321610770.
5
Anastrozole as a preventive agent in breast cancer.
Lancet. 2003 May 31;361(9372):1911-2. doi: 10.1016/S0140-6736(03)13522-2.
6
A comparison of risk perception and psychological morbidity in women with ductal carcinoma in situ and early invasive breast cancer.导管原位癌和早期浸润性乳腺癌女性的风险认知与心理疾病比较。
Breast Cancer Res Treat. 2003 Feb;77(3):285-93. doi: 10.1023/a:1021853302033.
7
Why men with prostate cancer want wider access to prostate specific antigen testing: qualitative study.前列腺癌男性患者希望更广泛地进行前列腺特异性抗原检测的原因：定性研究
BMJ. 2002 Oct 5;325(7367):737. doi: 10.1136/bmj.325.7367.737.
8
9
Information presentation and decisions to enter clinical trials: a hypothetical trial of hormone replacement therapy.信息呈现与进入临床试验的决策：一项激素替代疗法的假设性试验
Soc Sci Med. 2000 Aug;51(3):453-62. doi: 10.1016/s0277-9536(99)00477-3.
10
The framing of decisions and the psychology of choice.决策的框架与选择的心理学。
Science. 1981 Jan 30;211(4481):453-8. doi: 10.1126/science.7455683.
Zotero 插件